Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation-Reference-Cited by-同舟云学术

Corticosteroids for preventing graft-versus-host disease after allogeneic myeloablative stem cell transplantation

Published:2008-07-16 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Quellmann Susanne¹,Schwarzer Guido²,Hübel Kai³,Greb Alexander⁴,Engert Andreas¹,Bohlius Julia¹

Affiliation:

1. University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924

2. German Cochrane Center; Department of Medical Biometry and Statistics; University Medical Center Stefan-Meier-Str. 26 Freiburg Germany D-79104

3. University Hospital of Cologne; Department I of Internal Medicine, Center of Integrated Oncology Köln Bonn; Kerpener Str. 62 Cologne Germany 50924

4. Carl Schurz Strasse 8 Cologne Germany 50935

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD004885.pub2/fullpdf

Reference109 articles.

1. A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy;Atkinson;Australian and New Zealand Journal of Medicine,1991

2. Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial;Chao;Biology of blood and marrow transplantation : Journal of the American Society for Blood and Marrow Transplantation,2000

3. Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial;Deeg;Blood,1997

4. Cyclosporine (CSP) or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial;Deeg;Blood,2000

5. Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study;Ruutu;Blood,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corticosteroids as graft-versus-host disease prophylaxis for allogeneic hematopoietic cell transplant recipients with calcineurin inhibitor intolerance;Cytotherapy;2023-10

2. Long‐term outcomes of corticosteroid graft versus host disease prophylaxis in peripheral blood allogeneic haemopoietic stem cell transplant: a comparative cohort analysis;Internal Medicine Journal;2023-03-21

3. Reconstituting NK Cells After Allogeneic Stem Cell Transplantation Show Impaired Response to the Fungal Pathogen Aspergillus fumigatus;Frontiers in Immunology;2020-09-10

Do Benefits Outweigh Risks for Corticosteroid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in People with Diabetes Mellitus?

;International Journal of Chronic Obstructive Pulmonary Disease;2020-03

5. Graft versus host disease: New insights into A 2A receptor agonist therapy;Computational and Structural Biotechnology Journal;2015